MADY STOVALL: Open Payments
NPI 1699787697 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 9 payments from 4 companies in 2025. Trend: 2023 $291 · 2024 $259 · 2025 $1,080
Food & beverage: $981Education: $100
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $368 |
| Teva Pharmaceuticals USA, Inc. | 3 | $345 |
| E.R. Squibb & Sons, L.L.C. | 2 | $246 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
Products named: CAPLYTA, UZEDY, COBENFY, REXULTI.
Industry payments across TX — which companies pay providers there.
